Hensoldt Converts Knifefish Option Into Serial Order While ZF Takes On Spexer Production
Published on 11/20/2026 at 14:01 | Editorial boerse-global.deHensoldt has turned the framework it signed in June into a firm order. At the NEDS defence exhibition in Rotterdam, Germany and the Netherlands agreed with the company on series production and procurement of Knifefish electronic-warfare systems, activating the first option under that earlier agreement. The hardware is destined for installation in Piranha-5 vehicles, with the Dutch material and IT command authority COMMIT running the purchase on behalf of both nations — and signing for Germany as well.
The scope reaches beyond manufacturing. Qualification and testing are written into the same deal, so the contract fixes the work steps on the path to fielding the systems, not merely the delivery itself. A separate framework agreed with the Dutch economic ministry, also on the same day, is meant to bring Dutch companies and research institutions into the programme; the specific partners are to be named at a later stage.
That distinction matters for anyone tracking the stock. A framework sets the terms; a call-off converts them into revenue-bearing work. Hensoldt still has to show how quickly its swelling backlog turns into sales. In the first nine months of 2026, order intake jumped 77% to EUR 3.56 billion, while the order book stood at EUR 10.4 billion against EUR 7.1 billion a year earlier. Revenue for the same period rose 21% to EUR 1.86 billion, and adjusted earnings before interest, taxes, depreciation and amortisation climbed 33% to EUR 281 million.
Should investors sell immediately? Or is it worth buying Hensoldt?
Capacity is the other half of the equation. Hensoldt plans to have ZF ramp up series production of its Spexer radars and deliver them directly to customers, with intellectual property rights staying with Hensoldt. The arrangement separates responsibility for building and shipping the hardware from ownership of the product itself.
Management has been raising its sights. On 10 November the company reaffirmed a EUR 6 billion revenue ambition for 2030 and, for the first time, floated EUR 10 billion for 2035. From 2027 onward it expects annual top-line growth of 15% to 20%. For the full year 2026, Hensoldt is guiding to roughly EUR 2.8 billion in revenue, up from a previous EUR 2.75 billion — the first yardstick for how much of the order growth is already flowing through the accounts.
Analysts moved in step with the news flow. JPMorgan upgraded the shares from "Neutral" to "Overweight" on 11 November and lifted its price target to EUR 105 from EUR 100. Two other houses reiterated buy ratings the same day, one raising its target and one cutting it, leaving their new objectives at EUR 105 and EUR 100.
The equity itself slipped 1.9% to EUR 76.16 on the day of the announcements.
Ad
Hensoldt Stock: New Analysis - 20 November
Fresh Hensoldt information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
